Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.700
+0.050 (3.03%)
At close: May 22, 2026, 4:00 PM EDT
1.730
+0.030 (1.76%)
After-hours: May 22, 2026, 7:56 PM EDT

Autolus Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
92.6275.3910.121.76.381.51
Revenue Growth (YoY)
927.90%644.94%496.00%-73.38%323.23%522.73%
Cost of Revenue
102.9996.3711.39---
Gross Profit
-10.36-20.98-1.271.76.381.51
Selling, General & Admin
142.29131.87101.7246.7534.1331.87
Research & Development
112.17117.69138.44130.48136.23110.84
Other Operating Expenses
---4.171.510.68
Total Operating Expenses
254.46249.56240.16181.4171.87143.38
Operating Income
-264.82-270.54-241.43-179.7-165.49-141.87
Interest Income
15.3118.9832.3613.5110.530.26
Interest Expense
-37.65-36.67-9.29-45.07-10.39-1.11
Other Non-Operating Income (Expense)
-1.22.68-0.772.86--0.15
Total Non-Operating Income (Expense)
-23.54-15.0122.29-28.70.14-0.99
Pretax Income
-288.36-285.56-219.13-208.4-165.35-142.04
Provision for Income Taxes
-0.61-1.97-1.530.0223.37-0.06
Net Income
-288.97-287.53-220.66-208.38-141.98-142.1
Net Income to Common
-288.97-287.53-220.66-208.38-141.98-142.1
Shares Outstanding (Basic)
2662662551749572
Shares Outstanding (Diluted)
2662662551749572
Shares Change (YoY)
0.02%4.30%46.69%83.11%31.78%39.81%
EPS (Basic)
-1.09-1.08-0.86-1.20-1.50-1.97
EPS (Diluted)
-1.09-1.08-0.86-1.20-1.50-1.97
Shares Outstanding
266.16266.14266.13174.16173.0890.91
Free Cash Flow
-286.81-302.61-228.35-156.57-114.57-126.72
Free Cash Flow Per Share
-1.08-1.14-0.89-0.90-1.21-1.76
Gross Margin
-11.19%-27.83%-12.52%100.00%100.00%100.00%
Operating Margin
-285.90%-358.87%-2385.63%-10583.10%-2594.67%-9414.27%
Profit Margin
-309.38%-376.17%-2150.26%-12274.50%-2958.92%-9421.37%
FCF Margin
-309.65%-401.41%-2256.38%-9221.02%-1796.30%-8408.63%
EBITDA
-254.58-260.73-233.71-173.14-158.25-133.42
EBITDA Margin
-274.85%-345.85%-2309.39%-10196.50%-2481.18%-8853.02%
EBIT
-264.82-270.54-241.43-179.7-165.49-141.87
EBIT Margin
-285.90%-358.87%-2385.63%-10583.10%-2594.67%-9414.27%
Effective Tax Rate
0.62%0.69%0.70%-0.01%-14.13%0.04%
Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q